Clinical Trial: A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Clinical Activity of ABS-1230 in Pediatric Participants With KCNT1-related Epilepsy

U.S., May 23 -- ClinicalTrials.gov registry received information related to the study (NCT07600736) titled 'A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Clinical Activity of ABS-1230 in Pediatric Participants With KCNT1-related Epilepsy' on May 14.

Brief Summary: This trial will evaluate the safety, tolerability, pharmacokinetics, and clinical activity of ABS-1230 compared with placebo in participants with KCNT1-related epilepsy

Study Start Date: May, 2026

Study Type: INTERVENTIONAL

Condition: KCNT1-Related Epilepsy

Intervention: DRUG: ABS-1230

Once daily

DRUG: Placebo

Once daily

Recruitment Status: RECRUITING

Sponsor: Actio Biosciences, Inc.

Published by HT Digital Content Services with permission fro...